ArticleCommunications medicine2023

Radiomic tumor phenotypes augment molecular profiling in predicting recurrence free survival after breast neoadjuvant chemotherapy.

Rhea Chitalia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.